TrialHuman vaccines & immunotherapeutics2021

Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure.

Nicholas Hobart-Porter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.